Aventis Allegra New Prescriptions Up 9% Despite Availability Of OTC Claritin
Executive Summary
Allegra new prescriptions are up 9% despite the availability of OTC Claritin, Aventis Chief Operating Officer Richard Markham told analysts on a fourth quarter conference call Feb. 5
You may also be interested in...
Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition
WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines
Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition
WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines
Aventis Allegra Inventory Stable At Two Weeks; Price Flexibility “Minimal”
Aventis' inventory levels for Allegra have stabilized following first quarter wholesaler reductions triggered by the availability of OTC Claritin, VP-Investor Relations Arvind Sood told investors June 29